Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Statistics

Total Valuation

ASX:TLX has a market cap or net worth of AUD 4.77 billion. The enterprise value is 5.09 billion.

Market Cap	4.77B
Enterprise Value	5.09B

Important Dates

The last earnings date was Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:TLX has 338.40 million shares outstanding. The number of shares has decreased by -37.99% in one year.

Current Share Class	338.40M
Shares Outstanding	338.40M
Shares Change (YoY)	-37.99%
Shares Change (QoQ)	-4.06%
Owned by Insiders (%)	14.85%
Owned by Institutions (%)	33.40%
Float	275.43M

Valuation Ratios

The trailing PE ratio is 216.79 and the forward PE ratio is 127.95.

PE Ratio	216.79
Forward PE	127.95
PS Ratio	4.71
PB Ratio	7.41
P/TBV Ratio	n/a
P/FCF Ratio	324.62
P/OCF Ratio	138.25
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 83.20, with an EV/FCF ratio of 346.52.

EV / Earnings	307.93
EV / Sales	5.03
EV / EBITDA	83.20
EV / EBIT	118.85
EV / FCF	346.52

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.99.

Current Ratio	1.33
Quick Ratio	1.11
Debt / Equity	0.99
Debt / EBITDA	10.42
Debt / FCF	43.40
Interest Coverage	2.64

Financial Efficiency

Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 3.12%.

Return on Equity (ROE)	3.14%
Return on Assets (ROA)	2.08%
Return on Invested Capital (ROIC)	3.12%
Return on Capital Employed (ROCE)	3.15%
Revenue Per Employee	2.40M
Profits Per Employee	39,104
Employee Count	234
Asset Turnover	0.79
Inventory Turnover	10.97

Taxes

Income Tax	-2.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.98% in the last 52 weeks. The beta is 2.27, so ASX:TLX's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	-25.98%
50-Day Moving Average	18.67
200-Day Moving Average	24.43
Relative Strength Index (RSI)	34.45
Average Volume (20 Days)	3,545,346

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:TLX had revenue of AUD 1.01 billion and earned 16.54 million in profits. Earnings per share was 0.07.

Revenue	1.01B
Gross Profit	546.48M
Operating Income	42.86M
Pretax Income	13.79M
Net Income	16.54M
EBITDA	55.53M
EBIT	42.86M
Earnings Per Share (EPS)	0.07

Balance Sheet

The company has 315.98 million in cash and 637.96 million in debt, giving a net cash position of -321.99 million or -0.95 per share.

Cash & Cash Equivalents	315.98M
Total Debt	637.96M
Net Cash	-321.99M
Net Cash Per Share	-0.95
Equity (Book Value)	643.59M
Book Value Per Share	1.90
Working Capital	151.66M

Cash Flow

In the last 12 months, operating cash flow was 34.51 million and capital expenditures -19.81 million, giving a free cash flow of 14.70 million.

Operating Cash Flow	34.51M
Capital Expenditures	-19.81M
Free Cash Flow	14.70M
FCF Per Share	0.04

Margins

Gross margin is 53.94%, with operating and profit margins of 4.23% and 1.63%.

Gross Margin	53.94%
Operating Margin	4.23%
Pretax Margin	1.36%
Profit Margin	1.63%
EBITDA Margin	5.48%
EBIT Margin	4.23%
FCF Margin	1.45%

Dividends & Yields

ASX:TLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	37.99%
Shareholder Yield	n/a
Earnings Yield	0.35%
FCF Yield	0.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:TLX has an Altman Z-Score of 4.57 and a Piotroski F-Score of 5.

Altman Z-Score	4.57
Piotroski F-Score	5